Trump administration cancels contract with Moderna for development of Flu Vaccine due to its use of mRNA technology:
I heard a distinct "swoosh" days later...I hope he took his tutu with him.
What a funny fantasy...lol
You get a new jab everytime your betters tell you to, don't you Holli?LoLz at you nervous nelly alarmists.
mRNA COVID-19 vaccines have been associated with a small increase in the risk of myocarditis and pericarditis, particularly in male adolescents and young adults. This risk is rare and significantly lower than the risk of heart inflammation associated with COVID-19 infection itself.
Here's what the data suggest:
Important considerations:
- Risk is highest in young men: Myocarditis after mRNA vaccination is most commonly observed in adolescent and young adult males, particularly within 7 days of the second dose. Studies have shown reporting rates peaking in males aged 12-17 years.
- Specific vaccine and dose: Among the mRNA vaccines, the Moderna vaccine (mRNA-1273) has been associated with a higher risk of myocarditis compared to the Pfizer-BioNTech vaccine (BNT162b2) in young males. The risk is higher after the second dose than the first, and lower still after booster doses. However, some sources indicate that the risk after a booster dose remains elevated but is lower than after the second dose.
- Lower risk than COVID-19 infection: The risk of myocarditis after COVID-19 infection is significantly greater than the risk associated with vaccination. For example, one study found that COVID-19 infection was associated with an 11-fold increased risk of myocarditis in unvaccinated individuals, compared to a lower risk after vaccination.
- Mostly mild cases and favorable outcomes: Most cases of myocarditis associated with vaccination are reported to be mild, transient, and self-limiting. Patients usually recover quickly with rest and medications.
- Persistence of imaging findings: While most patients recover clinically, studies have shown that a high percentage of individuals who developed vaccine-associated myocarditis still show signs of myocardial injury on cardiac MRI scans months later. The long-term clinical and prognostic significance of these findings is currently unknown.
- The benefits of COVID-19 vaccination in preventing severe illness, hospitalization, and death from COVID-19 far outweigh the rare risk of myocarditis and pericarditis associated with the vaccine.
"Fuck you, just do what they tell you!" -Rage For The MachineYou get a new jab everytime your betters tell you to, don't you Holli?
LoLz at you nervous nelly alarmists.
mRNA COVID-19 vaccines have been associated with a small increase in the risk of myocarditis and pericarditis, particularly in male adolescents and young adults. This risk is rare and significantly lower than the risk of heart inflammation associated with COVID-19 infection itself.
Here's what the data suggest:
Important considerations:
- Risk is highest in young men: Myocarditis after mRNA vaccination is most commonly observed in adolescent and young adult males, particularly within 7 days of the second dose. Studies have shown reporting rates peaking in males aged 12-17 years.
- Specific vaccine and dose: Among the mRNA vaccines, the Moderna vaccine (mRNA-1273) has been associated with a higher risk of myocarditis compared to the Pfizer-BioNTech vaccine (BNT162b2) in young males. The risk is higher after the second dose than the first, and lower still after booster doses. However, some sources indicate that the risk after a booster dose remains elevated but is lower than after the second dose.
- Lower risk than COVID-19 infection: The risk of myocarditis after COVID-19 infection is significantly greater than the risk associated with vaccination. For example, one study found that COVID-19 infection was associated with an 11-fold increased risk of myocarditis in unvaccinated individuals, compared to a lower risk after vaccination.
- Mostly mild cases and favorable outcomes: Most cases of myocarditis associated with vaccination are reported to be mild, transient, and self-limiting. Patients usually recover quickly with rest and medications.
- Persistence of imaging findings: While most patients recover clinically, studies have shown that a high percentage of individuals who developed vaccine-associated myocarditis still show signs of myocardial injury on cardiac MRI scans months later. The long-term clinical and prognostic significance of these findings is currently unknown.
- The benefits of COVID-19 vaccination in preventing severe illness, hospitalization, and death from COVID-19 far outweigh the rare risk of myocarditis and pericarditis associated with the vaccine.
Indeed I do, and you assjamokes are very, very lucky to have the likes of me around this moribund forum.Bastard Factory is very fortunate to have a tiny handful of internet knuckleheads that know waay more about virology and immunization than the scientists who have studied such things for decades.
#Blessed
Bastard Factory is very fortunate to have a tiny handful of internet knuckleheads that know waay more about virology and immunization than the scientists who have studied such things for decades.
Companies like Pfizer and Merck have dedicated grant programs.
True to form, this is what you answer with when you've got nothing.“I seen a YouTube video of an angry shouting guy in a pickup truck, and he broke the scam wide open!”